###begin article-title 0
###xml 48 53 <span type="species:ncbi:9606">Human</span>
Differentiation of Insulin-Producing Cells from Human Neural Progenitor Cells
###end article-title 0
###begin p 1
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: SK has a consulting relationship with and owns shares of the company StemCells.
###end p 1
###begin p 2
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author Contributions:</bold>
Author Contributions: YH, XG, XX, and SKK designed the study. YH, XG, and XX performed the experiments. YH and SKK contributed to writing the paper.
###end p 2
###begin p 3
currency Current address: Department of Gastroenterological Surgery, 21st Century COE Program, Kobe University Graduate School of Medicine, Kobe, Japan
###end p 3
###begin article-title 4
Producing Insulin from Neural Cells
###end article-title 4
###begin title 5
Background
###end title 5
###begin p 6
Success in islet-transplantation-based therapies for type 1 diabetes, coupled with a worldwide shortage of transplant-ready islets, has motivated efforts to develop renewable sources of islet-replacement tissue. Islets and neurons share features, including common developmental programs, and in some species brain neurons are the principal source of systemic insulin.
###end p 6
###begin title 7
Methods and Findings
###end title 7
###begin p 8
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
Here we show that brain-derived human neural progenitor cells, exposed to a series of signals that regulate in vivo pancreatic islet development, form clusters of glucose-responsive insulin-producing cells (IPCs). During in vitro differentiation of neural progenitor cells with this novel method, genes encoding essential known in vivo regulators of pancreatic islet development were expressed. Following transplantation into immunocompromised mice, IPCs released insulin C-peptide upon glucose challenge, remained differentiated, and did not form detectable tumors.
###end p 8
###begin title 9
Conclusion
###end title 9
###begin p 10
###xml 185 190 <span type="species:ncbi:9606">human</span>
###xml 246 251 <span type="species:ncbi:9606">human</span>
Production of IPCs solely through extracellular factor modulation in the absence of genetic manipulations may promote strategies to derive transplantable islet-replacement tissues from human neural progenitor cells and other types of multipotent human stem cells.
###end p 10
###begin p 11
The search for cells that can secrete insulin need not be limited to pancreatic precursors; cells derived from neural progenitors can also produce insulin and respond to glucose
###end p 11
###begin title 12
Introduction
###end title 12
###begin p 13
###xml 67 68 67 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b01">1</xref>
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b02">2</xref>
###xml 480 491 480 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila,</italic>
###xml 550 551 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b03">3</xref>
###xml 552 553 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b04">4</xref>
###xml 705 706 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b05">5</xref>
###xml 806 807 806 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b06">6</xref>
###xml 937 938 937 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b07">7</xref>
###xml 939 940 939 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b08">8</xref>
###xml 969 970 969 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b02">2</xref>
###xml 1172 1173 1172 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b09">9</xref>
###xml 1174 1176 1174 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b10">10</xref>
###xml 1177 1179 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b11">11</xref>
###xml 1180 1182 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b12">12</xref>
###xml 1183 1185 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b13">13</xref>
###xml 430 436 <span type="species:ncbi:9606">humans</span>
###xml 480 490 <span type="species:ncbi:7227">Drosophila</span>
###xml 871 876 <span type="species:ncbi:10090">mouse</span>
###xml 1371 1376 <span type="species:ncbi:9606">human</span>
Advances in transplant-based therapy for type 1 diabetes mellitus [1] and a dearth of cadaveric pancreatic islets of Langerhans have focused interest on developing renewable sources of transplant-ready islet-replacement tissues. Pancreatic islets derive from embryonic endoderm, but display features of neurons, including a shared set of cell-autonomous developmental regulators [2]. Islets are the principal source of insulin in humans, but in some invertebrate species, such as Drosophila, brain neurons are the main source of circulating insulin [3,4]. The similarities between islet cells and neurons are further underscored by the demonstration of insulin gene transcription in the vertebrate brain [5], although it remains unclear whether these vertebrate neurons produce or secrete insulin protein [6]. Moreover, recent studies also suggest that in some settings, mouse pancreatic epithelial cells can engender neuron-like cells [7,8]. These and other findings [2] suggest that common, ancient developmental programs may govern the differentiation of islet cells and neurons. Methods promoting neural differentiation by embryonic stem (ES) cells have been adapted [9,10,11,12,13] to derive insulin-producing cells (IPCs), but it remains unclear whether such IPCs were derived from neural progenitors, or whether a neural-based strategy can generate transplantable human IPCs.
###end p 13
###begin p 14
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b14">14</xref>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 259 264 <span type="species:ncbi:9606">human</span>
###xml 544 549 <span type="species:ncbi:9606">human</span>
Neural cells derive from multipotent progenitor cells, and recently, clonal human neural progenitor cells that remained multipotent and karyotypically stable through at least 15 passages were purified by flow-cytometry-based methods [14]. The availability of human neural progenitor cells allowed us to investigate whether inductive signals involved in normal pathways of islet development could direct these neural progenitors to develop into glucose-responsive IPCs. Here we describe experimental strategies for developing IPCs directly from human neural stem cells.
###end p 14
###begin title 15
Methods
###end title 15
###begin p 16
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 64 76 <span type="species:ncbi:9606">participants</span>
All studies were performed in accordance with appropriate human participants' approval according to Stanford University Institutional Review Board guidelines.
###end p 16
###begin title 17
Cell Lines and Culture Conditions
###end title 17
###begin p 18
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b14">14</xref>
###xml 1120 1121 1119 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1670 1671 1668 1669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1949 1950 1946 1947 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sc>
###xml 2164 2169 2158 2163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 2303 2305 2297 2299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b10">10</xref>
###xml 2909 2910 2901 2902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 590 595 <span type="species:ncbi:9606">human</span>
###xml 1241 1247 <span type="species:ncbi:9913">bovine</span>
###xml 2001 2007 <span type="species:ncbi:9913">bovine</span>
###xml 2596 2601 <span type="species:ncbi:10090">mouse</span>
The human neurosphere (NS) cell lines (line numbers 1651, 1664, and 1673) were established following enrichment for AC133+ cells, as previously described [14], although none of the cell lines was expanded from a single cell, and they are therefore not clonal. The different cell lines were from distinct donors and karyotypically normal. They gave comparable results, but line 1664 produced less insulin by stage 4 in our protocol than the other cell lines. Following cell thaw, NSs were expanded in suspension culture, and in each case were used between passages 5 and 7. Undifferentiated human NS cells (stage 1) were cultured and expanded in medium containing X-VIVO15 (Cambrex, Walkersville, Maryland, United States), N2 supplement (Invitrogen, Carlsbad, California, United States), 2 mug/ml heparin, 10 ng/ml leukemia inhibitory factor (Chemicon, Temecula, California, United States), 20 ng/ml epidermal growth factor (R&D Systems, Minneapolis, Minnesota, United States), and 20 ng/ml fibroblast growth factor-2 (R&D Systems), and they were frozen after enzymatic dissociation. At stage 2, we thawed and cultured 107 cells in medium made from a 1:1 mixture of glucose-free DMEM (Invitrogen) and F-12 medium (Invitrogen) containing 0.2% bovine serum albumin (Sigma, St. Louis, Missouri, United States), N2 supplement, 2 mug/ml heparin, 10 ng/ml leukemia inhibitory factor, 20 ng/ml epidermal growth factor, and 20 ng/ml fibroblast growth factor-2. The final concentration of glucose in stage 2 was 5 mM. Cultures were fed weekly for up to 2 wk. Cells formed NSs during stages 1 and 2. After 2 wk, we transferred 40-80 NSs containing a total of approximately 2-4 x 105 cells to single wells in plates coated with 0.005% poly-L-ornithine (Sigma) and 3 mug/ml fibronectin (Invitrogen). These were cultured for 2 wk (stage 3) in a 1:1 mixture of low-glucose DMEM and F-12 media containing 100 mg/l apo-transferrin (Sigma), 288 mg/l glucose, 73 mg/l L-glutamine, 1.69 g/l sodium bicarbonate, 25 mug/ml bovine insulin (Sigma), 20 nM progesterone, 100 muM putrescine, 30 nM sodium selenite, and penicillin/streptomycin. Stage 3 medium was supplemented with 2 muM all-trans retinoic acid (RA) (Sigma) and had a final glucose concentration of either 5 or 17 mM. At stage 4, cells were cultured in N2 medium [10] supplemented with 10 mM nicotinamide (Sigma) and 10 nM insulin-like growth factor-1 (R&D Systems) for up to 6 d. Stage 4 medium included 17.3 mM glucose. During stage 3 and 4, medium was changed every other day. To examine the effect of Sonic hedgehog (Shh) (R&D Systems), we added 300 nM mouse Shh in PBS every other day during stage 4. To quantify neurite outgrowths per cluster, 20 Shh-treated or control stage 4 IPC clusters were photographed under light microscopy, and digitized images were used to score neurites. Data are presented as the average +/- the standard error of the mean. Two-tailed t tests were conducted to determine statistical significance.
###end p 18
###begin title 19
RT-PCR
###end title 19
###begin p 20
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 540 547 540 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0020103-t001">Table 1</xref>
Total RNA was prepared by using TRIZOL (Invitrogen) and RQ1 RNase-free DNase (Promega, Madison, Wisconsin, United States). For cDNA synthesis, random sequence primers were used to prime reverse transcription reactions and synthesis was carried out by Thermoscript RT (Invitrogen). A total of 35 cycles of PCR were performed using Platinum Taq High Fidelity DNA Polymerase (Invitrogen). GAPDH expression was used to normalize input template cDNA to analyze relative gene expression. Primer sequences and gene accession numbers are listed in Table 1. To confirm their identity, DNA products from PCR reactions were excised, cloned, and sequenced.
###end p 20
###begin title 21
Immunohistochemistry and Morphometry
###end title 21
###begin p 22
###xml 280 290 <span type="species:ncbi:10141">guinea pig</span>
###xml 367 372 <span type="species:ncbi:10090">mouse</span>
###xml 411 417 <span type="species:ncbi:9986">rabbit</span>
###xml 458 463 <span type="species:ncbi:10090">mouse</span>
###xml 495 500 <span type="species:ncbi:10090">mouse</span>
###xml 559 565 <span type="species:ncbi:9986">rabbit</span>
###xml 653 659 <span type="species:ncbi:9986">rabbit</span>
###xml 729 735 <span type="species:ncbi:9986">rabbit</span>
###xml 797 802 <span type="species:ncbi:10090">mouse</span>
###xml 868 873 <span type="species:ncbi:10090">mouse</span>
###xml 968 973 <span type="species:ncbi:10090">mouse</span>
###xml 1001 1006 <span type="species:ncbi:10090">mouse</span>
###xml 1037 1043 <span type="species:ncbi:9986">rabbit</span>
Cell clusters were fixed in 4% paraformaldehyde, embedded in HistoGel (Richard-Allan Scientific, Kalamazoo, Michigan, United States), and then embedded in paraffin. We performed immunohistochemistry on 6-mum tissue sections. We used primary antibodies at the following dilutions: guinea pig anti-insulin, 1:200 (Linco Research, St. Charles, Missouri, United States), mouse anti-beta-tubulin III, 1:500 (Sigma); rabbit anti-C-peptide, 1:100 (Linco Research); mouse anti-Nestin, 1:200 (Chemicon); mouse anti-Ki67, 1:100 (Novocastra, Newcastle, United Kingdom); rabbit anti-cleaved caspase-3, 1:200 (Cell Signaling, Beverly, Massachusetts, United States); rabbit anti-glucagon, 1:200 (Dako, Carpinteria, California, United States); rabbit anti-Glut-2, 1:200 (ADI, San Antonio, Texas, United States); mouse anti-proinsulin, 1:500 (O. Madsen, Hagedorn, Gentofte, Denmark); mouse anti-glucokinase, 1:200 (C. Newgard, Duke University, Durham, North Carolina, United States); mouse anti-GFAP, 1:1,000 (Dako); mouse anti-MAP2, 1:500 (Sigma); and rabbit anti-Olig2, 1:1,000 (H. Takebayashi, National Institute for Physiological Sciences, Okazaki, Japan). Confocal immunofluorescence microscopy with an optical slice thickness of 0.6 mum was performed on a Bio-Rad (Hercules, California, United States) MRC1000.
###end p 22
###begin p 23
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b15">15</xref>
Cell counting and point-counting morphometry were performed using standard morphometric techniques [15]. To obtain representative results, all quantification of immunostaining was performed by counting numbers of positive-stained cells and dividing by the area of total tissues using a standard 10 x 10 microscope grid. For quantification of cells expressing Nestin, Ki67, beta-tubulin III, activated caspase-3, insulin, or C-peptide, NS-derived cell clusters were fixed, and sectioned to generate 7-mum-thick tissue sections. Appropriately stained cells were counted in a minimum of ten random microscopic fields obtained from at least ten cell clusters per condition.
###end p 23
###begin title 24
In Situ Hybridization
###end title 24
###begin p 25
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b16">16</xref>
###xml 8 13 <span type="species:ncbi:9606">human</span>
We used human insulin cDNA (320 bp) cloned in plasmid pCR4-TOPO (Invitrogen) as a template for in vitro transcription to produce riboprobes with a digoxigenin-RNA labeling kit (Ambion, Austin, Texas, United States), performed hybridization with IPC cluster sections as described [16], and used DIG Nucleic Acid Detection Kit (Roche, Indianapolis, Indiana, United States) for development according to the manufacturer's instructions.
###end p 25
###begin title 26
Insulin C-Peptide Quantification and In Vitro Insulin Secretion Assay
###end title 26
###begin p 27
###xml 377 381 <span type="species:ncbi:9913">calf</span>
At each stage, 300 NS or IPC clusters were handpicked, washed with PBS, and homogenized; then intracellular C-peptide content was measured with a C-peptide ELISA kit (American Laboratory Products Company, Windham, New Hampshire, United States). Stage 4 IPC clusters were cultured in glucose-free RPMI (Invitrogen) supplemented with 2.8 mM glucose, 20 mM HEPES, and 10% newborn calf serum (Invitrogen) for at least 2-3 h. At the end of these washes, no insulin was detectable in the wash supernatant using an ELISA kit (American Laboratory Products Company). Fifty IPC clusters were handpicked, transferred to a 24-well plate, and incubated for 2 h at 37 degreesC in the presence of 2.8 mM glucose, 25 mM glucose, or 25 mM sucrose. Supernatants were then harvested for enzyme-linked immunosorption assay (ELISA)-based quantification of released insulin.
###end p 27
###begin title 28
IPC Transplantation and Physiologic Tests
###end title 28
###begin p 29
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 907 908 907 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1028 1029 1026 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 579 583 <span type="species:ncbi:10090">mice</span>
###xml 629 634 <span type="species:ncbi:9606">human</span>
###xml 751 756 <span type="species:ncbi:9606">human</span>
All animal studies were performed in accordance with Stanford University Animal Care and Use Guidelines. Under general anesthesia, 9- to 10-wk-old male NOD scid mice (purchased from Jackson Laboratories, Bar Harbor, Maine, United States) were engrafted with 1,000 handpicked IPC clusters in the right and left subcapsular renal space (500 IPC clusters each) or received a sham transplant of saline solution. Transplantation of more IPC clusters in a renal graft site was not feasible because of the size of the clusters. Two weeks after IPC cluster transplantation, we subjected mice to an overnight fast. Then we measured serum human C-peptide before and 30 min after intraperitoneal injection with 3 g of glucose per kilogram of body weight using a human C-peptide ELISA kit. When stage 4 IPC clusters were transplanted, tumors were not observed 4 wk after engraftment, the maximum period of observation (n = 5). All data represent the average (from the indicated number of samples) +/- standard error of the mean. Two-tailed t tests were conducted to determine statistical significance.
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
Glucose Restriction Initiates IPC Development
###end title 31
###begin p 32
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b14">14</xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b17">17</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b18">18</xref>
###xml 560 569 560 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figures 1</xref>
###xml 574 575 574 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g002">2</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b19">19</xref>
###xml 750 752 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b20">20</xref>
###xml 1016 1024 1013 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 386 391 <span type="species:ncbi:9606">human</span>
Culture media with high glucose concentrations have been useful for isolating and maintaining progenitor cell populations from the central and peripheral nervous systems [14,17] and for permitting differentiation by neurogenic cells [18]. We routinely expanded NS cultures in medium containing 37 mM glucose, a level 5- to 6-fold higher than physiologic glucose concentration. Isolated human neural progenitors spontaneously aggregate in these conditions to produce a cell cluster called a NS, and 85%-90% of NS cells produce the intermediary filament Nestin (Figures 1 and 2), a putative marker of neural stem and progenitor cells [19]. Prolonged exposure to high glucose levels can also severely reduce insulin expression in pancreatic beta-cells [20]. Thus, we postulated that glucose reduction might blunt neurogenic programs by NSs and promote alternate fates, including development of IPCs. Therefore, we switched NS culture conditions from high glucose (37 mM, "stage 1") to low glucose (5 mM, "stage 2"; see Figure 1A) to initiate development.
###end p 32
###begin p 33
###xml 458 466 455 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g002">Figure 2</xref>
###xml 621 623 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b21">21</xref>
###xml 624 626 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b22">22</xref>
###xml 627 629 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b23">23</xref>
###xml 642 675 639 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">En1, Hb9, Isl1, Hoxc6, NRSF/REST,</italic>
###xml 680 686 677 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx6.1</italic>
###xml 749 757 746 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 759 760 756 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">1</xref>
###xml 850 852 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b14">14</xref>
To assess developmental changes resulting from glucose reduction and later culture modifications, we examined NS cell composition, and expression of gene products known to regulate or define in vivo fates of embryonic neural or islet cells. A beta-tubulin III isoform produced in differentiating neurons was not detected in stage 1 cells, whereas expression of Ki67, an S-phase-associated nuclear antigen, was expressed in the majority of stage 1 cells (see Figure 2). Genes specifying transcription factors essential for in vivo differentiation of lineage-restricted neural progenitors and their differentiated progeny [21,22,23], including En1, Hb9, Isl1, Hoxc6, NRSF/REST, and Nkx6.1, were expressed at low or undetectable levels in stage 1 (see Figure 1B-1C), consistent with the reported multipotency of proliferating NSs grown in high glucose [14].
###end p 33
###begin p 34
###xml 66 74 66 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 145 153 145 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g002">Figure 2</xref>
###xml 297 315 297 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx6.1, NRSF/REST,</italic>
###xml 342 351 339 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figures 1</xref>
###xml 357 358 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g002">2</xref>
###xml 402 420 399 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neurogenin3 (ngn3)</italic>
###xml 426 434 423 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 566 568 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b24">24</xref>
###xml 569 571 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b25">25</xref>
###xml 572 574 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b26">26</xref>
###xml 577 583 574 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx6.1</italic>
###xml 588 592 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ngn3</italic>
###xml 672 680 669 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 1004 1005 1001 1002 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
After 2 wk at stage 2, NS-derived cells remained in clusters (see Figure 1A), but Nestin and Ki67 were expressed in fewer than 35% of cells (see Figure 2), indicating possible differentiation of cells toward lineage-restricted fates. Consistent with this view, we detected increased expression of Nkx6.1, NRSF/REST, and beta-tubulin III (see Figures 1B and 2). We also detected increased expression of Neurogenin3 (ngn3) (see Figure 1C), a transcription factor expressed in differentiating neurons, and required for development of pancreatic islet progenitor cells [24,25,26]. Nkx6.1 and ngn3 expression were never observed in NS cultures maintained in 37 mM glucose (see Figure 1B; data not shown). These data suggest that glucose restriction initiates developmental programs known to promote differentiation of mammalian neural and neuroendocrine cells. As shown below, insulin expression in NS-derived cells required culture in low-glucose medium at stage 2, but we did not consistently detect insulin+ cells by immunohistochemistry until stage 4.
###end p 34
###begin title 35
RA Promotes IPC Development
###end title 35
###begin p 36
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b27">27</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b28">28</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b27">27</xref>
###xml 449 457 441 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 619 630 611 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1, Cdx1,</italic>
###xml 635 641 627 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxA3,</italic>
###xml 714 716 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b29">29</xref>
###xml 717 719 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b30">30</xref>
###xml 722 733 714 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1, Cdx1,</italic>
###xml 738 743 730 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxA3</italic>
###xml 871 872 863 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 936 944 927 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 950 951 941 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">1</xref>
###xml 1079 1080 1070 1071 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1147 1148 1137 1138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1219 1227 1209 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g003">Figure 3</xref>
###xml 1656 1658 1646 1648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b31">31</xref>
###xml 1659 1661 1649 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b32">32</xref>
###xml 1700 1704 1690 1694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1</italic>
###xml 1709 1714 1699 1704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxA3</italic>
###xml 1894 1933 1884 1923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">brachyury, flk-1, myosin light chain-2,</italic>
###xml 1938 1950 1928 1937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-globin,</italic>
###xml 1985 1993 1972 1980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 2147 2149 2134 2136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b31">31</xref>
###xml 2150 2152 2137 2139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b32">32</xref>
###xml 2153 2155 2140 2142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b33">33</xref>
###xml 2235 2243 2222 2230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g002">Figure 2</xref>
###xml 2266 2276 2253 2263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">En1, ngn3,</italic>
###xml 2281 2284 2268 2271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb9</italic>
###xml 2300 2308 2287 2295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 2314 2315 2301 2302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">1</xref>
###xml 2390 2391 2374 2375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2459 2467 2443 2451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g002">Figure 2</xref>
###xml 2669 2677 2653 2661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 2762 2764 2746 2748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b21">21</xref>
###xml 2107 2112 <span type="species:ncbi:9606">human</span>
RA induces development of primitive endodermal cells from a subset of embryonal carcinoma cell lines, and is an endogenous signal that directs development of posterior organs like the pancreas from embryonic endoderm [27,28]. In vivo exposure to RA is sufficient to induce ectopic development of insulin-expressing tissue in the anterior foregut [27]. Moreover, stage 2 NS-derived cells expressed RA receptors including RAR-alpha and RAR-gamma (see Figure 1C), indicating competence for RA signals. To investigate whether RA could stimulate development of NS-derived cells toward an IPC fate, we measured expression of Pdx1, Cdx1, and FoxA3, transcription factors that regulate gastrointestinal organ development [29,30]. Pdx1, Cdx1, and FoxA3 expression was induced in "stage 3," when cell clusters were allowed to adhere to pre-coated wells at a density of 40-80 NSs/cm2 and cultured in low-glucose medium with 2 muM RA for 2 wk (see Figure 1A and 1C). We then tested other concentrations of RA and other plating densities. NS cells exposed to 100 nM RA at 20, 40, or 80 NSs/cm2 and NS cells exposed to 2 muM RA at a plating density of 20 NSs/cm2 did not express these markers or insulin at a later stage ("stage 4"; Figure 3A; data not shown). Thus, higher doses of RA induced markers of posterior fate in NS-derived cells, a dosage response like that seen during RA patterning of posterior gut development in vivo. Moreover, this response was sensitive to plating density, revealing that additional cell-non-autonomous factors may regulate this response. Mesoderm develops in close association with gastrointestinal endoderm both in vivo and in vitro [31,32]. Thus, detection of gut markers like Pdx1 and FoxA3 in NS-derived cell cultures raised the possibility that mesodermal cells might co-develop. However, we did not detect expression of known markers of mesoderm formation, including brachyury, flk-1, myosin light chain-2, and beta-globin, at any stage in our cultures (see Figure 1B). By contrast, mesoderm development invariably accompanies endoderm development in embryoid bodies derived from human ES cells or embryonic germ cells [31,32,33]. In stage 3 cultures, Nestin and Ki67 expression was nearly extinguished (see Figure 2), while expression of En1, ngn3, and Hb9 increased (see Figure 1B and 1C). While their numbers increased slightly during stage 3, beta-tubulin III+ cells composed fewer than 10% of cells in NS-derived clusters (see Figure 2), suggesting that the majority of differentiated cells had acquired non-neural fates. Consistent with this interpretation, we also did not detect expression of homeodomain proteins Hoxc6 or Hoxb9 (see Figure 1B; data not shown), which are induced by RA in spinal cord neuronal precursor cells [21].
###end p 36
###begin p 37
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b16">16</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b34">34</xref>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxA3</italic>
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1,</italic>
###xml 360 373 360 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Patched (Ptc)</italic>
###xml 378 394 378 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smoothened (Smo)</italic>
###xml 410 418 410 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g003">Figure 3</xref>
###xml 583 586 583 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh</italic>
###xml 588 596 588 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g003">Figure 3</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b19">19</xref>
###xml 644 647 644 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptc</italic>
###xml 736 739 736 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptc</italic>
###xml 961 973 961 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxA3, Pdx1,</italic>
###xml 1050 1053 1050 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh</italic>
###xml 1094 1109 1094 1109 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Desert hedgehog</named-content>
###xml 1113 1128 1113 1128 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Indian hedgehog</named-content>
###xml 1130 1138 1130 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g003">Figure 3</xref>
###xml 1217 1219 1217 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b21">21</xref>
###xml 1300 1308 1300 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g003">Figure 3</xref>
###xml 1314 1315 1314 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g003">3</xref>
###xml 1358 1361 1358 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptc</italic>
###xml 1374 1382 1374 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g003">Figure 3</xref>
###xml 1450 1462 1450 1462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1, FoxA3,</italic>
###xml 1476 1484 1476 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g003">Figure 3</xref>
###xml 1622 1624 1622 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b16">16</xref>
###xml 1625 1627 1625 1627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b34">34</xref>
###xml 1677 1679 1677 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b21">21</xref>
###xml 1094 1109 <span type="species:ncbi:262775">Desert hedgehog</span>
RA can activate signaling through the Hedgehog (Hh) pathway, and recent studies show that Hh signals control development of embryonic pancreatic islets in vivo [16,34]. To elucidate the mechanisms underlying RA-induced expression of markers like FoxA3 and Pdx1, we examined Hh signaling during IPC development. We detected expression of the Hedgehog receptors Patched (Ptc) and Smoothened (Smo) at all stages (Figure 3B), consistent with the possibility that NS-derived cells are competent for Hh signaling. However, we did not detect NS expression of genes encoding Hh ligands like Shh (Figure 3B), similar to previous studies [19]. Increased Ptc transcription is a known consequence of Shh signaling, but we did not detect changes of Ptc expression during stages 1-4, consistent with the absence of detectable expression of Hh ligands. To test directly whether the absence of Hh signaling was required for expression of endodermal or islet markers, including FoxA3, Pdx1, and insulin, we added Shh protein to stage 4 cultures, which do not express Shh or genes encoding other Hh ligands like Desert hedgehog or Indian hedgehog (Figure 3C). At 300 nM, a dose used to induce neuronal development in ES cell cultures [21], Shh produced a significant increase in neurite outgrowth in NS-derived cells (Figure 3D and 3E; see Methods), and resulted in increased Ptc expression (Figure 3F). Moreover, Shh treatment during stage 4 eliminated expression of Pdx1, FoxA3, and insulin (Figure 3F). These data are reminiscent of prior studies demonstrating that excess endodermal Shh signaling disrupts pancreas development in vivo [16,34]. Thus, in contrast to the response of ES cells [21], RA treatment of NS-derived cells does not stimulate endogenous Hh signaling. The lack of Hh signals in NS-derived cells blunts neural differentiation and permits differentiation toward endocrine-like cell fates.
###end p 37
###begin title 38
Insulin Expression by IPCs
###end title 38
###begin p 39
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ngn3, Pdx1,</italic>
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb9</italic>
###xml 79 81 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b22">22</xref>
###xml 240 242 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b19">19</xref>
###xml 243 245 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b35">35</xref>
###xml 358 360 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b20">20</xref>
###xml 653 661 647 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g003">Figure 3</xref>
###xml 950 958 944 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g003">Figure 3</xref>
###xml 1213 1215 1204 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b36">36</xref>
###xml 1302 1310 1293 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 1415 1417 1406 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b37">37</xref>
ngn3, Pdx1, and Hb9 are essential factors for mammalian beta-cell development [22], and their expression in stage 3 suggested the potential for deriving IPCs. Insulin expression has not, to our knowledge, been reported in NS-derived cells [19,35]. Moderate hyperglycemia is a potent stimulus for beta-cell differentiation and expansion in vivo and in utero [20], so we tested whether exposure of stage 3 cells to elevated glucose levels could induce insulin expression. Semi-quantitative RT-PCR measures of insulin mRNA expression showed that exposure of cultures grown in 5 mM glucose at stage 3 to 17 mM glucose at stage 4 induced insulin expression (Figure 3A). Growth of cells at stage 2 in 5 mM glucose followed by exposure in stages 3 and 4 to 17 mM glucose also resulted in insulin expression at stage 4, but at lower levels. By contrast, no insulin was expressed by cultures maintained in 5 mM glucose or 17 mM glucose throughout stages 2-4 (Figure 3A). Thus, reduction of glucose in stage 2 growth medium followed by a later increase in glucose at stage 3 or 4 was essential for development of IPCs. Insulin-like growth factor-1 may promote insulin secretion and prevent apoptosis of beta-cells in vivo [36], and addition of this factor at stage 4 reduced apoptosis approximately 10-fold (see Figure 1A; data not shown). Nicotinamide, which can stimulate in vivo pancreatic endocrine cell differentiation [37], did not affect cell survival, but did increase insulin C-peptide expression approximately 1.5- to 2-fold (data not shown). Thus, simultaneous exposure to high glucose levels, insulin-like growth factor-1, and nicotinamide optimized insulin expression at stage 4. Comparable results were obtained with three independently derived NS lines.
###end p 39
###begin p 40
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ngn3</italic>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b25">25</xref>
###xml 145 163 145 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1, FoxA3, Isl1,</italic>
###xml 168 174 168 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx6.1</italic>
###xml 223 225 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b22">22</xref>
###xml 343 347 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ngn3</italic>
###xml 398 410 395 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Isl1, FoxA3,</italic>
###xml 415 419 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1</italic>
###xml 436 444 433 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 450 451 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">1</xref>
###xml 523 528 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1,</italic>
###xml 533 539 530 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxA3,</italic>
###xml 956 964 950 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Coinciding with the onset of high insulin expression levels in mouse islets, ngn3 expression is virtually extinguished [25], while expression of Pdx1, FoxA3, Isl1, and Nkx6.1 in islet beta-cells is maintained or increased [22]. Similarly, we noted that IPC maturation from stage 3 to 4 was accompanied by increased insulin expression, reduced ngn3 expression, and increased or maintained levels of Isl1, FoxA3, and Pdx1 expression (see Figure 1B and 1C). Thus, tissues derived from neural progenitor cells express insulin, Pdx1, and FoxA3, markers typically co-expressed in foregut-derived tissues. Expression of these markers suggests differentiation of some neural progenitor cells toward an endoderm-like fate. We were unable to detect expression of Pdx1 and FoxA3 using immunohistochemical methods in stage 4 IPCs, (data not shown). We also did not detect expression of Nkx6.1 or islet amyloid polypeptide, markers of mature pancreatic beta-cells (see Figure 1C; data not shown). Thus, the sequence of gene expression accompanying formation of IPCs from NSs was similar but not identical to that described for differentiating pancreatic beta-cells, and further molecular studies are required to determine the degree of endoderm-like differentiation of cells in IPCs.
###end p 40
###begin p 41
###xml 99 107 99 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">Figure 4</xref>
###xml 169 170 169 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 283 291 283 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">Figure 4</xref>
###xml 361 362 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 397 405 394 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g005">Figure 5</xref>
###xml 407 408 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g005">5</xref>
###xml 419 420 416 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 506 514 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 636 644 633 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g005">Figure 5</xref>
###xml 646 647 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g005">5</xref>
###xml 731 739 728 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g005">Figure 5</xref>
###xml 741 742 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g005">5</xref>
###xml 750 752 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b38">38</xref>
###xml 821 822 818 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 880 888 877 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g005">Figure 5</xref>
###xml 890 891 887 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g005">5</xref>
###xml 1042 1043 1039 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 575 580 <span type="species:ncbi:9606">human</span>
We detected expression of insulin protein by immunohistochemistry in 90% of stage 4 cell clusters (Figure 4). An average of 26% of cells in stage 4 clusters were insulin+, and appeared healthy, with abundant cytoplasm and a well-defined nucleus delineated by the nuclear stain 7AAD (Figure 4A). Of the cells composing stage 4 clusters, 45% were beta-tubulin III+, none of which contained insulin (Figure 5A-5C). Insulin+ cells showed little or no co-expression of neural stem cell markers like Nestin (see Figure 1), or other markers of neural lineages known to develop from human neural progenitors, like MAP2 (differentiated neurons; Figure 5D-5F), Olig2 (multipotent precursors, bipotent glial precursors, and oligodendrocytes; Figure 5J-5L; see [38]), or myelin basic protein (data not shown). Occasional rare insulin+ cells expressed detectable GFAP (a marker of astrocytes; Figure 5G-5I). Thus, while we cannot completely rule out the possibility that some neural cell types expressed insulin, these data suggest that nearly all insulin+ cells produced in stage 4 cultures were non-neuronal.
###end p 41
###begin p 42
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 70 79 70 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g002">Figures 2</xref>
###xml 84 85 84 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">4</xref>
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 349 350 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 362 370 359 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">Figure 4</xref>
###xml 372 373 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">4</xref>
###xml 579 587 576 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">Figure 4</xref>
###xml 589 590 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">4</xref>
###xml 673 674 670 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 748 756 745 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">Figure 4</xref>
###xml 876 884 873 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">Figure 4</xref>
###xml 522 527 <span type="species:ncbi:9606">human</span>
Nuclei in insulin+ cells were not stained by an antibody to Ki67 (see Figures 2 and 4B), suggesting that insulin+ cells at stage 4 are post-mitotic, like mature pancreatic beta-cells. Immunostaining with specific antibodies revealed proinsulin and C-peptide, an internal portion of the proinsulin translation product, in the cytoplasm of all insulin+ cells (see Figure 4D-4G and 4O), supporting our conclusion that insulin protein was produced in stage 4 IPCs. In situ hybridization with antisense riboprobes specific for human insulin mRNA labeled 25%-30% of stage 4 cells (see Figure 4H-4J), providing further evidence of insulin production. We observed only rare insulin+ cells stained by antibodies specific for activated caspase-3 (<0.3%; see Figure 4K) or TUNEL assay (data not shown). In stage 4 cell clusters we did not consistently detect expression of glucagon (see Figure 4L), pancreatic polypeptide, or somatostatin by immunohistochemistry. The absence of glucagon gene expression in our IPC cultures was further confirmed by RT-PCR (data not shown). Thus, like in pancreatic islets, insulin was the principal hormone produced by IPCs. However, the composition of IPCs was distinct from that of pancreatic islets, and further studies are required to determine the basis for this difference.
###end p 42
###begin p 43
###xml 94 102 94 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">Figure 4</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b39">39</xref>
###xml 405 413 405 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">Figure 4</xref>
###xml 474 482 474 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g002">Figure 2</xref>
###xml 639 647 639 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">Figure 4</xref>
###xml 846 847 846 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1009 1011 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b40">40</xref>
###xml 1324 1326 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b39">39</xref>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 211 217 <span type="species:ncbi:9913">bovine</span>
###xml 288 294 <span type="species:ncbi:9913">bovine</span>
###xml 1127 1132 <span type="species:ncbi:9606">human</span>
To quantify insulin expression in IPCs, we used a human insulin C-peptide-specific ELISA (see Figure 4P). By ELISA, we did not detect C-peptide in stage 3 or stage 4 culture media, which contained supplementary bovine insulin. Thus, use of a C-peptide assay did not detect medium-derived bovine insulin in measures of IPC insulin content [39]. C-peptide levels at stages 1-3 were low or undetectable (see Figure 4P), consistent with the lack of immunostainable insulin (see Figure 2) in cells at these earlier stages. Similarly, in cultures maintained in 17 mM glucose during stages 1-4 ("HHHH"), C-peptide levels were not detectable (see Figure 4P). In cell clusters exposed to 5 mM glucose in stages 2-3 then switched to 17 mM glucose at stage 4 ("HLLH"), insulin C-peptide levels were 0.36 fmol per cluster, and the average number of C-peptide+ cells per cluster was 200. Thus, we estimate 0.0018 fmol C-peptide per NS-derived IPC. A single beta-cell contains approximately 0.6 fmol C-peptide and insulin [40], so we calculate that insulin C-peptide content in one stage 4 IPC is approximately 0.3% of the level in isolated human beta-cells. Collectively, these experiments confirm that IPCs transcribe and translate insulin, and rule out that insulin measured in IPCs is derived from medium, as shown in another system [39].
###end p 43
###begin title 44
IPCs Are Glucose Responsive
###end title 44
###begin p 45
###xml 174 175 171 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 187 196 184 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figures 1</xref>
###xml 199 200 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">4</xref>
###xml 508 516 505 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">Figure 4</xref>
###xml 1006 1014 1003 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">Figure 4</xref>
###xml 1144 1145 1139 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1286 1288 1281 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b41">41</xref>
###xml 1624 1632 1619 1627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">Figure 4</xref>
###xml 1638 1639 1633 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">4</xref>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
###xml 751 756 <span type="species:ncbi:10090">mouse</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
###xml 832 837 <span type="species:ncbi:9606">human</span>
###xml 865 870 <span type="species:ncbi:9606">Human</span>
###xml 901 906 <span type="species:ncbi:10090">mouse</span>
###xml 1127 1132 <span type="species:ncbi:9606">human</span>
###xml 1244 1249 <span type="species:ncbi:9606">human</span>
Glucokinase and glucose transporters like Glut-2 are essential regulators of glucose responses in pancreatic beta-cells, and expression of these regulators in stage 4 insulin+ cells (see Figures 1C, 4M, and 4N) suggested that IPCs could sense and respond to glucose. To test whether IPCs respond appropriately to glucose stimulation, we measured insulin release in static batch in vitro assays. We found that IPC insulin release increased markedly following a step increase of glucose from 2.8 to 25 mM (see Figure 4Q). To examine whether IPCs are similarly responsive to glucose stimulation in vivo, we performed a series of IPC grafting experiments in immunocompromised recipient mice. Two weeks following engraftment (1,000 IPC-containing clusters/mouse), recipient mice and sham-transplanted controls were fasted overnight, and human C-peptide levels measured. Human C-peptide was undetectable in mouse sera prior to glucose challenge, or following glucose challenge of sham-transplanted controls (see Figure 4R). In contrast, 30 min after intraperitoneal glucose challenge of IPC recipients we detected 6.1 +/- 1.2 pmol/l human C-peptide (p < 0.001), approximately 0.5%-1% of serum C-peptide levels observed following engraftment of 2,000 human islet equivalents in a prior study [41]. Thus, IPCs respond to glucose challenge in vivo by releasing insulin C-peptide. Analysis of IPC graft sites 4 wk after transplantation revealed nests of transplanted cells without obvious tumor formation. Histologic analysis and immunohistochemical detection revealed that C-peptide-expressing cells persisted in the graft site (see Figure 4S and 4T). Thus, engrafted IPCs remained differentiated and survived up to a month following transplantation.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b42">42</xref>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 420 425 <span type="species:ncbi:10090">mouse</span>
###xml 748 753 <span type="species:ncbi:9606">human</span>
There is widespread interest in developing tissue replacement strategies for treatment of human disorders like diabetes mellitus and Parkinson disease. While much attention has been focused on the promise of ES cells for tissue replacement, recent work suggests that neural stem cells, like ES cells, may have an unusually broad differentiation potential. For example, Gage and colleagues demonstrated the conversion of mouse neural stem cells to the endothelial lineage, indicating that plasticity is a bona fide property of cultured neural stem cells [42]. These results were also unexpected because endothelial cells and neuronal cells normally derive, respectively, from mesoderm and ectoderm, distinct embryonic germ layers. Here we show that human neural stem cells have a similarly broad differentiation potential, and that specific in vitro culture conditions can divert neural stem-derived cells from neural lineages toward a fate with endocrine and endodermal characteristics.
###end p 47
###begin p 48
###xml 522 523 519 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 974 976 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b22">22</xref>
###xml 1053 1060 1044 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx6.1,</italic>
###xml 1103 1111 1094 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g001">Figure 1</xref>
###xml 1131 1132 1122 1123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1442 1443 1430 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b07">7</xref>
###xml 1444 1445 1432 1433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b08">8</xref>
###xml 1578 1580 1566 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b43">43</xref>
###xml 1798 1799 1780 1781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2094 2095 2073 2074 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 3004 3012 2983 2991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0020103-g004">Figure 4</xref>
###xml 3258 3260 3237 3239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b10">10</xref>
###xml 3261 3263 3240 3242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b41">41</xref>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 2833 2838 <span type="species:ncbi:9606">human</span>
###xml 2966 2970 <span type="species:ncbi:10090">mice</span>
###xml 3230 3238 <span type="species:ncbi:9606">patients</span>
Our study shows that application of endogenous signals governing pancreas development to human neural progenitor cells can generate glucose-responsive IPCs. Systematic variation of the identity, concentration, and sequence of these signals led to discovery of methods culminating in IPC formation. However, there are limitations to our findings that should be noted. First, our molecular analysis of differentiating IPCs showed that they remain distinct from mature pancreatic islet beta-cells; in other words, the insulin+ cells derived by our methods are not mature beta-cells. For example, reverse transcriptase polymerase chain reaction confirmed that IPCs were enriched for a combination of gene products that approximate those expressed in developing pancreatic islet cells. However, the temporal sequence of expression of some of these products, like glucokinase, Glut-2, and Pdx1 does not precisely recapitulate that observed in the embryonic pancreas (reviewed in [22]), and transcription of other genes typically expressed in beta-cells, like Nkx6.1, was not detected in later stage IPCs (see Figure 1). Thus, the insulin+ cells derived in this study are not bona fide beta-cells. Further experimentation may elucidate the basis for these differences, revealing the extent of neural progenitor cell development toward an endocrine cell fate. Recent studies suggest that neural cells can be derived from adult pancreatic epithelium [7,8], adding to a growing body of data demonstrating numerous similarities in neural and pancreatic endocrine development (reviewed in [43]). In light of these similarities, we speculate that methods leading to the production of beta-cell factors like Nkx6.1 in stage 4 clusters may enhance the beta-cell-like qualities of neural-progenitor-derived insulin+ cells, and thereby permit differentiation of tissues that more closely resemble endoderm-derived islet cells. Second, our immunohistochemical analysis shows that stage 4 insulin-expressing cells do not express markers like Nestin, beta-tubulin III, MAP2, or Olig2, suggesting that these insulin+ cells are non-neuronal, but we cannot formally rule out the alternate possibility that our methods produced neural cells capable of secreting insulin. Third, we have not demonstrated fully that the stimulus-secretion coupling apparatus in IPCs is similar to that in pancreatic islets. While insulin release by IPCs produced here appears to be glucose-sensitive, both in vitro and in vivo, future work should elaborate whether IPC insulin is stored in dense-core secretory vesicles, and whether secretogogues or secretion potentiators other than glucose (like amino acids or sulfonylureas) stimulate insulin release by IPCs, like in pancreatic islets. Lastly, we have not ameliorated glucose regulation in diabetic animal models with the human IPCs described here. Serum levels of insulin C-peptide expression achieved following IPC transplantation in glucose-challenged mice were less than 1% of normal (see Figure 4). Thus, we did not attempt IPC transplantations in overtly diabetic animals, since prior studies suggest that insulin production at 10% of normal (or greater) may be required to improve glucose regulation in diabetic patients and animal models [10,41]. Additional studies to test the impact of transplanted IPCs in animal models of diabetes therefore await production of IPCs capable of insulin secretion at levels higher than achieved here.
###end p 48
###begin p 49
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b13">13</xref>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b44">44</xref>
###xml 868 869 868 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 875 876 875 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 903 905 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b45">45</xref>
###xml 915 916 912 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1068 1069 1065 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1214 1215 1208 1209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1343 1345 1337 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b14">14</xref>
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 175 180 <span type="species:ncbi:9606">human</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 607 612 <span type="species:ncbi:9606">human</span>
###xml 785 790 <span type="species:ncbi:9606">human</span>
Nevertheless, compared to other methods for IPC development from human stem cells [13,44], our methods produced insulin at the highest levels yet achieved from an expandable, human stem-cell-derived tissue. Multiple experimental approaches were taken to demonstrate that these IPCs transcribe, translate, and secrete insulin, and to rule out the possibility that insulin measured in IPCs derived from the culture media. In vitro studies demonstrate that IPCs release insulin in a glucose-responsive manner, like islets. Moreover, IPCs transplanted into mice remained differentiated and released circulating human insulin in a glucose-dependent manner. Thus, for the first time, we demonstrate moderately efficient production of glucose-responsive IPCs from an expandable population of human stem cells. Current islet transplantation methods require an estimated 5 x 108 to 109 beta-cells per recipient [45]. From 106 cells at stage 2, we produced an average of 200-400 clusters with approximately 2,000 cells per cluster; approximately 25% of these cells are C-peptide+ and release 0.5%-1% of C-peptide secreted by beta-cells. Based strictly on these yields, we would need to expand IPC production approximately 105-fold to meet the need for one transplantation. Undifferentiated NSs can be readily expanded through at least a dozen passages [14], suggesting sufficient cell numbers could be generated to "scale up" this protocol for transplant-based therapies.
###end p 49
###begin p 50
###xml 592 594 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b46">46</xref>
###xml 595 597 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b47">47</xref>
###xml 598 600 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0020103-b48">48</xref>
###xml 289 294 <span type="species:ncbi:9606">human</span>
###xml 837 842 <span type="species:ncbi:9606">human</span>
We did not exhaust all possible factor combinations in our study: we speculate that further method refinements may improve the efficiency of NS conversion into IPCs, as well as IPC insulin synthesis and stimulus-secretion coupling, the hallmark functions of mature beta-cells. If so, then human neural stem cells may serve as a valuable model for elucidating the mechanisms and factors that regulate neuroendocrine cell differentiation. For instance, addition of glucagon-like peptide-1, TGF-beta ligands, or other factors that potentiate beta-cell maturation, growth, and insulin secretion [46,47,48] may improve the methods described here. Because our method is based solely on extracellular factor modulation, in the absence of genetic manipulations, it could serve as the basis for developing replacement islets from a wide range of human stem cells, including neural stem cells and ES cells.
###end p 50
###begin title 51
Supporting Information
###end title 51
###begin title 52
Accession Numbers
###end title 52
###begin p 53
###xml 131 140 131 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">brachyury</italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdx1</italic>
###xml 171 186 171 186 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Desert hedgehog</named-content>
###xml 200 203 200 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">En1</italic>
###xml 217 222 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flk-1</italic>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FoxA3</italic>
###xml 313 316 313 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb9</italic>
###xml 330 335 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxb9</italic>
###xml 349 354 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxc6</italic>
###xml 397 412 397 412 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Indian hedgehog</named-content>
###xml 426 430 426 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Isl1</italic>
###xml 490 510 490 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myosin light chain-2</italic>
###xml 541 545 541 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ngn3</italic>
###xml 558 564 558 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx6.1</italic>
###xml 578 587 578 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRSF/REST</italic>
###xml 617 621 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1</italic>
###xml 635 638 635 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptc</italic>
###xml 716 719 705 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh</italic>
###xml 730 733 719 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smo</italic>
###xml 746 757 735 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-globin</italic>
###xml 171 186 <span type="species:ncbi:262775">Desert hedgehog</span>
###xml 368 373 <span type="species:ncbi:9606">human</span>
The National Center for Biotechnology Information () accession numbers for the genes and gene products discussed in this paper are brachyury (AF012130), Cdx1 (NM_000209), Desert hedgehog (NM_021044), En1 (NM_001426), flk-1 (AF035121), FoxA3 (NM_004497), GAPDH (NM_002046), GFAP (NM_002055), glucokinase (M90299), Hb9 (NM_005515), Hoxb9 (NM_024017), Hoxc6 (NM_004503), human insulin cDNA (J00265), Indian hedgehog (NM_002181), Isl1 (NM_002202), MAP2 (U01828), myelin basic protein (M13577), myosin light chain-2 (X57542), Nestin (NM_006617), ngn3 (AF234829), Nkx6.1 (NM_006168), NRSF/REST (U13879), Olig2 (NM_005806), Pdx1 (NM_000209), Ptc (U59464), RAR-alpha (NM_000964), RAR-beta (BC060794), RAR-gamma (NM_000966), Shh (L38518), Smo (AH007453), beta-globin (NM_000518), and beta-tubulin III (BC000748).
###end p 53
###begin title 54
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient Summary
###end title 54
###begin title 55

###end title 55
###begin title 56
Background
###end title 56
###begin p 57
The transplantation of insulin-secreting cells has proved effective in treating severe cases of type 1 diabetes, but currently such cells have to be collected from donors after death. The process of isolation is very laborious and does not provide sufficient numbers of cells to permit wider use of this transplant-based treatment. A renewable source of these cells would be very valuable. Previous work has shown that some nerve cells can also produce insulin.
###end p 57
###begin title 58
What Did the Researchers Do?
###end title 58
###begin p 59
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
They took stem cells that had come from human brains and treated them with a variety of different substances, including glucose, to see if they could alter the way the cells normally develop. They managed to manipulate the stem cells so that they developed into more mature cells that secreted insulin, and could respond to glucose. They put the cells into mice, and found that there, too, they could respond to glucose by producing insulin, albeit at very low levels.
###end p 59
###begin title 60
###xml 29 37 <span type="species:ncbi:9606">Patients</span>
What Do the Results Mean for Patients?
###end title 60
###begin p 61
These findings are a first step towards producing a renewable source of insulin-producing cells; however, the amount of insulin produced was quite low. In addition much more work will need to be done to ensure the safety of the procedure over the long term.
###end p 61
###begin title 62
Where Can I Get More Information?
###end title 62
###begin p 63
The National Diabetes Information Clearinghouse, part of the National Institute of Diabetes and Digestive and Kidney Diseases has an information page on islet cell transplantation:
###end p 63
###begin p 64
Diabetes UK, a charity, also has information:
###end p 64
###begin p 65
###xml 116 121 <span type="species:ncbi:9606">human</span>
We thank Graeme McLean, Ursula Ehmann, and Dongping He for expert technical assistance, and StemCells for providing human neural progenitor cell lines. Drs. Irving L. Weissman, Nobuko Uchida, Ann Tsukamoto, Matthias Hebrok, James Wells, and Julie Baker, and Mr. Jeremy Heit provided valuable advice and comments on the manuscript. YH is a Juvenile Diabetes Research Foundation (JDRF) physician postdoctoral fellow. This work was supported by grants from the JDRF, Riva Foundation, Hillblom Foundation, and Programs in Molecular and Genetic Medicine and Interdisciplinary Translational Research at Stanford University. The funders of this work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
###end article-title 67
###begin article-title 68
Pancreatic organogenesis-Developmental mechanisms and implications for therapy
###end article-title 68
###begin article-title 69
Ablation of insulin-producing neurons in flies: Growth and diabetic phenotypes
###end article-title 69
###begin article-title 70
###xml 128 138 128 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 128 138 <span type="species:ncbi:7227">Drosophila</span>
Nutrient-dependent expression of insulin-like peptides from neuroendocrine cells in the CNS contributes to growth regulation in Drosophila
###end article-title 70
###begin article-title 71
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo
###end article-title 71
###begin article-title 72
Brain insulin: Regulation, mechanisms of action and function
###end article-title 72
###begin article-title 73
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages
###end article-title 73
###begin article-title 74
Adult pancreas generates multipotent stem cells and pancreatic and non-pancreatic progeny
###end article-title 74
###begin article-title 75
Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets
###end article-title 75
###begin article-title 76
Growth inhibitors promote differentiation of insulin-producing tissues from embryonic stem cells
###end article-title 76
###begin article-title 77
Expression of Pax4 in embryonic stem cells promotes differentiation of Nestin-positive progenitor and insulin-producing cells
###end article-title 77
###begin article-title 78
Analysis of insulin-producing cells during in vitro differentiation from feeder-free embryonic stem cells
###end article-title 78
###begin article-title 79
###xml 19 24 <span type="species:ncbi:9606">human</span>
Differentiation of human embryonic stem cells into insulin-producing clusters
###end article-title 79
###begin article-title 80
###xml 20 25 <span type="species:ncbi:9606">human</span>
Direct isolation of human central nervous system stem cells
###end article-title 80
###begin article-title 81
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pbx1</italic>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ipf1</italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus
###end article-title 81
###begin article-title 82
Notochord repression of endodermal Sonic hedgehog permits pancreas development
###end article-title 82
###begin article-title 83
Isolation of a stem cell for neurons and glia from the mammalian neural crest
###end article-title 83
###begin article-title 84
Dynamic changes in glucose metabolism accompanying the expression of the neural phenotype after differentiation in PC12 cells
###end article-title 84
###begin article-title 85
Global analysis of gene expression in neural progenitors reveals specific cell-cycle, signaling, and metabolic networks
###end article-title 85
###begin article-title 86
###xml 108 112 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions
###end article-title 86
###begin article-title 87
Directed differentiation of embryonic stem cells into motor neurons
###end article-title 87
###begin article-title 88
Gene expression cascades in pancreatic development
###end article-title 88
###begin article-title 89
Critical role of the transcriptional repressor neuron-restrictive silencer factor in the specific control of connexin36 in insulin-producing cell lines
###end article-title 89
###begin article-title 90
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neurogenins</italic>
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">atonal</italic>
neurogenins a novel family of atonal-related bHLH transcription factors, are putative mammalian neuronal determination genes that reveal progenitor cell heterogeneity in the developing CNS and PNS
###end article-title 90
###begin article-title 91
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neurogenin3</italic>
neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas
###end article-title 91
###begin article-title 92
Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors
###end article-title 92
###begin article-title 93
###xml 65 74 <span type="species:ncbi:7955">zebrafish</span>
Retinoic acid signaling is required for a critical early step in zebrafish pancreatic development
###end article-title 93
###begin article-title 94
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
All-trans-retinoic acid induces differentiation of ducts and endocrine cells by mesenchymal/epithelial interactions in embryonic pancreas
###end article-title 94
###begin article-title 95
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Post implantation expression patterns indicate a role for the mouse forkhead/HNF-3 alpha, beta and gamma genes in determination of the definitive endoderm, chordamesoderm and neuroectoderm
###end article-title 95
###begin article-title 96
Endoderm development: From patterning to organogenesis
###end article-title 96
###begin article-title 97
Development of definitive endoderm from embryonic stem cells in culture
###end article-title 97
###begin article-title 98
###xml 77 82 <span type="species:ncbi:9606">human</span>
Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells
###end article-title 98
###begin article-title 99
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro
###end article-title 99
###begin article-title 100
Sonic Hedgehog directs specialized mesoderm differentiation in the intestine and pancreas
###end article-title 100
###begin article-title 101
###xml 19 24 <span type="species:ncbi:9606">human</span>
Gene expression in human neural stem cells: Effects of leukemia inhibitory factor
###end article-title 101
###begin article-title 102
beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass
###end article-title 102
###begin article-title 103
###xml 74 79 <span type="species:ncbi:9606">human</span>
Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells
###end article-title 103
###begin article-title 104
Olig genes are expressed in a heterogeneous population of precursor cells in the developing spinal cord
###end article-title 104
###begin article-title 105
Insulin staining of ES cell progeny from insulin uptake
###end article-title 105
###begin article-title 106
###xml 11 16 <span type="species:ncbi:9606">human</span>
Successful human islet isolation utilizing recombinant collagenase
###end article-title 106
###begin article-title 107
Improved in vivo pancreatic islet function after prolonged in vitro islet culture
###end article-title 107
###begin article-title 108
Cell fusion-independent differentiation of neural stem cells to the endothelial lineage
###end article-title 108
###begin article-title 109
Embryonic stem cells and islet replacement in diabetes mellitus
###end article-title 109
###begin article-title 110
###xml 22 27 <span type="species:ncbi:9606">human</span>
Insulin production by human embryonic stem cells
###end article-title 110
###begin article-title 111
Stem cell therapy for diabetes: Do we need to make beta cells?
###end article-title 111
###begin article-title 112
###xml 145 149 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats
###end article-title 112
###begin article-title 113
Glucagon-like Peptide-1: Regulation of insulin secretion and therapeutic potential
###end article-title 113
###begin article-title 114
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development
###end article-title 114
###begin title 115
Abbreviations
###end title 115
###begin p 116
enzyme-linked immunosorption assay
###end p 116
###begin p 117
embryonic stem
###end p 117
###begin p 118
Hedgehog
###end p 118
###begin p 119
insulin-producing cell
###end p 119
###begin p 120
neurosphere
###end p 120
###begin p 121
retinoic acid
###end p 121
###begin p 122
Sonic hedgehog
###end p 122
###begin title 123
Figures and Tables
###end title 123
###begin title 124
###xml 51 56 <span type="species:ncbi:9606">Human</span>
Development of Cells Expressing Islet Markers from Human Neural Progenitor Cells
###end title 124
###begin p 125
(A) Outline of four-stage differentiation protocol, essential factor manipulations at each stage, and stage-specific cell cluster morphology. Original magnification, 100x.
###end p 125
###begin p 126
###xml 116 121 <span type="species:ncbi:9606">human</span>
(B) RT-PCR analysis of gene expression by stages 1-4 cell clusters, in stage 4 samples with RT omitted (-RT) and in human fetal spinal cord as a control ("C").
###end p 126
###begin p 127
(C) RT-PCR analysis of expression during stages 1-4 of pancreatic and endodermal markers. Fetal pancreas RNA served as a control ("C").
###end p 127
###begin title 128
###xml 81 86 <span type="species:ncbi:9606">Human</span>
Immunohistochemical Detection of Neural Markers and Insulin during Stages 1-4 of Human Neural Progenitor Cell Differentiation
###end title 128
###begin p 129
Immunofluorescent images were obtained by confocal microscopy and are representative of at least ten samples for each antibody. We detected insulin in only stage 4 IPCs, consistent with RT-PCR results. Distribution of insulin staining is localized in the cytoplasm. Immunofluorescent detection of Ki67, a nuclear marker of proliferating cells, showed stage 4 IPCs are predominantly non-proliferating, similar to mature pancreatic islets. Original magnification, 630x.
###end p 129
###begin title 130
The Sequence of Glucose Concentration Changes, Cell Density, and Absence of Hh Signals Are Essential for Development of IPCs
###end title 130
###begin p 131
###xml 456 457 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
(A) RT-PCR analysis of insulin gene expression for different glucose concentrations and cell densities during stages 2-4. High glucose is designated "H"; low glucose designated "L." Thus, maintenance of glucose at high concentration in stages 1-4 is abbreviated as "HHHH"; exposure to high glucose in stage 1, followed by reduction of glucose in stages 2-4 is abbreviated "HLLL"; and so forth. Cell clusters analyzed here were cultured at 40-80 clusters/cm2 except where indicated ("low density"). Fetal pancreas RNA served as a control ("C").
###end p 131
###begin p 132
(B) RT-PCR analysis of Hh signaling factors during stages 1-4 and in fetal spinal cord as a control ("C").
###end p 132
###begin p 133
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh</italic>
###xml 54 75 54 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Desert hedgehog (Dhh)</italic>
###xml 81 102 81 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Indian hedgehog (Ihh)</italic>
###xml 54 69 <span type="species:ncbi:262775">Desert hedgehog</span>
(C) RT-PCR analysis of stage 4 IPC expression of Shh, Desert hedgehog (Dhh), and Indian hedgehog (Ihh). Control ("C") is a spinal cord sample.
###end p 133
###begin p 134
(D) Neurite outgrowth in control stage 4 IPC clusters, and in stage 4 IPC clusters exposed to 300 nM Shh. Original magnification, 100x.
###end p 134
###begin p 135
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(E) Quantification of neurite outgrowth per control or Shh-treated stage 4 IPC cluster. *, P < 0.001.
###end p 135
###begin p 136
###xml 49 66 49 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptc, FoxA3, Pdx1,</italic>
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">insulin</italic>
(F) RT-PCR analysis of IPC cluster expression of Ptc, FoxA3, Pdx1, and insulin following treatment with Shh at stage 4. Control ("C") is fetal pancreas sample.
###end p 136
###begin title 137
Stage 4 IPCs Express Characteristic Pancreatic beta-Cell Markers and Are Glucose-Responsive
###end title 137
###begin p 138
(A-C) Immunofluorescent images of stage 4 IPCs were obtained by confocal microscopy and are representative of at least ten samples for each probe. Shown is simultaneous immunofluorescent staining of insulin and either the nuclear marker 7AAD (A) or Ki67 (B). (C) Lack of immunostaining upon omission of the anti-insulin primary antibody.
###end p 138
###begin p 139
(D-G) Detection of insulin C-peptide in cells stained by anti-insulin antibodies. There is complete overlap between immunostained C-peptide and insulin in the cytoplasm.
###end p 139
###begin p 140
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 113 118 <span type="species:ncbi:9606">human</span>
(H and I) Representative in situ hybridization with antisense riboprobes specific for human insulin on sectioned human fetal pancreatic islet cells (H) or a stage 4 IPC cluster (I).
###end p 140
###begin p 141
(J) Sense control probe in situ hybridization on a stage 4 IPC cluster.
###end p 141
###begin p 142
(K-O) Simultaneous immunofluorescent detection of insulin and cleaved caspase-3 (K), glucagon (L), Glut-2 (M), glucokinase (N), or proinsulin (O).
###end p 142
###begin p 143
###xml 65 70 <span type="species:ncbi:9606">human</span>
(P) Intracellular C-peptide content of IPCs during stages 1-4 by human C-peptide-specific ELISA.
###end p 143
###begin p 144
###xml 201 202 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(Q) In vitro secretion assay of stage 4 IPCs. Insulin release followed a step increase from 2.8 mM to 25 mM glucose, but not following exposure to 25 mM sucrose, which served as an osmotic control. *, p < 0.001.
###end p 144
###begin p 145
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
(R) Serum human C-peptide detection 2-wk after sham or IPC cluster transplantation in NOD scid mice. Samples were obtained before or 30 min after intraperitoneal glucose challenge (IPGTT).
###end p 145
###begin p 146
(S) Lack of tumor growth after renal transplantation of stage 4 IPCs (graft indicated by white circle).
###end p 146
###begin p 147
###xml 37 42 <span type="species:ncbi:9606">human</span>
(T) Immunohistochemical detection of human C-peptide expression in stage 4 IPCs (cells stained brown) 2-wk after engraftment; bar is 20 mum.
###end p 147
###begin p 148
Original magnification of (H-J) and (T) was 250x. All other photomicrographs' original magnification was 630x.
###end p 148
###begin title 149
Stage 4 IPCs Do Not Express Markers of Differentiated Neural Cells
###end title 149
###begin p 150
(A-C) Immunohistochemical detection of beta-tubulin III (A) and insulin (B) in stage 4 cells, and a merge of both images (C).
###end p 150
###begin p 151
(D-F) Immunohistochemical detection of MAP2 (D) and insulin (E) in stage 4 cells, and a merge of both images (F).
###end p 151
###begin p 152
(G-I) Immunohistochemical detection of GFAP (G) and insulin (H) in stage 4 cells, and a merge of both images (I).
###end p 152
###begin p 153
###xml 99 100 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(J-L) Immunohistochemical detction of Olig2 at stage 1 (J) and stage 4 (K) and merged view of Olig2+ and insulin+ cells at stage 4 (L). Original magnification was 630x.
###end p 153
###begin title 154
Specific PCR Primers and Gene Accession Numbers
###end title 154
###begin p 155
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
a National Center for Biotechnology Information () accession numbers
###end p 155
###begin p 156
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Citation:</bold>
###xml 93 98 <span type="species:ncbi:9606">human</span>
Citation: Hori Y, Gu X, Xie X, Kim SK (2005) Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med 2(4): e103.
###end p 156

